MMP2 rs243845 was significantly associated with breast cancer risk among post-menopausal women only (OR 0.73, 95% CI 0.61,0.88 for TT vs CC genotypes; adjusted p for interaction = 0.036). Here, MMP2 is linked to breast carcinoma.